- Home
- FAMI vs SCNI Comparison
FAMI vs SCNI Comparison
Compare FAMI & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- SCNI
- Stock Information
- Founded
- FAMI 2015
- SCNI 2003
- Country
- FAMI China
- SCNI Israel
- Employees
- FAMI N/A
- SCNI N/A
- Industry
- FAMI Packaged Foods
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FAMI Consumer Staples
- SCNI Health Care
- Exchange
- FAMI Nasdaq
- SCNI Nasdaq
- Market Cap
- FAMI 2.1M
- SCNI 1.9M
- IPO Year
- FAMI 2018
- SCNI N/A
- Fundamental
- Price
- FAMI $1.78
- SCNI $2.91
- Analyst Decision
- FAMI
- SCNI
- Analyst Count
- FAMI 0
- SCNI 0
- Target Price
- FAMI N/A
- SCNI N/A
- AVG Volume (30 Days)
- FAMI 137.6K
- SCNI 15.6K
- Earning Date
- FAMI 05-27-2025
- SCNI 05-07-2025
- Dividend Yield
- FAMI N/A
- SCNI N/A
- EPS Growth
- FAMI N/A
- SCNI N/A
- EPS
- FAMI N/A
- SCNI N/A
- Revenue
- FAMI $64,131,332.00
- SCNI $658,000.00
- Revenue This Year
- FAMI N/A
- SCNI N/A
- Revenue Next Year
- FAMI N/A
- SCNI N/A
- P/E Ratio
- FAMI N/A
- SCNI N/A
- Revenue Growth
- FAMI N/A
- SCNI N/A
- 52 Week Low
- FAMI $1.43
- SCNI $1.90
- 52 Week High
- FAMI $11.28
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- FAMI 50.56
- SCNI 60.01
- Support Level
- FAMI $1.62
- SCNI $2.66
- Resistance Level
- FAMI $2.22
- SCNI $2.96
- Average True Range (ATR)
- FAMI 0.18
- SCNI 0.18
- MACD
- FAMI 0.03
- SCNI 0.04
- Stochastic Oscillator
- FAMI 29.03
- SCNI 93.15
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.